The CDC looked at the 6.7 million people who received at least one dose of the coronavirus vaccine and where their race or ethnicity is known. Among the known yet limited data, 359,934 were Black compared to over 4 million white Americans.
Since the vaccination was first distributed in the US, there have been over 66 million vaccines administered per KFF’s tracking data.
But the distribution of the vaccine among racial and ethnic groups may differ.
“Based on vaccinations with known race/ethnicity, the share of vaccinations among Black people is smaller than their share of cases in all 16 reporting states and smaller than their share of deaths in 15 states,” KFF wrote in January.
A CDC report takes a deeper dive of the demographics for people who have received at least one dose between December 14, 2020 and January 14, 2021. Race and ethnicity data were only available for 6.7 million people, or 51.9% of the vaccine recipients, so this data is limited and doesn’t give a full picture of all Americans who have been vaccinated.
Among those recipients for whom race was known, non-Hispanic white Americans made up the largest share who received at least one dose at 60.4%, while only 5.4% were Black. Again, it is possible that more Black Americans received the dose, given the race for nearly half of the reported data is unknown.
Insider’s analysis of six states with reported vaccination data by race and ethnicity and that are among the states with the 10 largest Black populations shows Black Americans have a lower share than white Americans in receiving the vaccine. Insider did note that it was still early on in the rollout of the vaccine.
But some Black Americans are unsure whether they are getting the vaccine. A Pew Research survey in November found that only 42% of Black Americans said they would probably or definitely get the vaccine.
“It’s not so much that Black people or other minorities are unwilling to take [the vaccines], but there is really unequal access to the cutting edge of medicine and medical technology — and that is, in some respects, a bigger problem than reticence to take new treatments,” Tina Sacks, assistant professor at UC Berkeley’s School of Social Welfare previously told Insider.
Credit: Source link
